Inventor
Juerg Lehmann
Inventor
San Diego, CA, US
Overview
Patents· 17 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Pprimary
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations31%
C07DHeterocyclic compounds27%
A61KPreparations for medical, dental or toiletry purposes25%
Y02ATechnologies for adaptation to climate change11%
C07CAcyclic or carbocyclic compounds5%
PatentTitleYear
10,781,1803-phenyl-pyrazole derivatives as modulators of the 5-HT202010,624,9005-HT202010,272,0945-HT2C receptor agonists and compositions and methods of use20199,676,758'1-heteroaryl-indoline-4-carboxamides as modulators of GPR52 useful for the treatment or prevention of disorders related thereto'20179,522,133'Substituted 1,2,3,4-tetrahydrocyclopenta[b]indol-3-yl)acetic acid derivatives useful in the treatment of autoimmune and inflammatory disorders'20169,126,932'Substituted 1,2,3,4-tetrahydrocyclopenta[b]indol-3-yl)acetic acid derivatives useful in the treatment of autoimmune and inflammatory disorders'20159,108,969'Substituted tricyclic acid derivatives as S1P1 receptor agonists useful in the treatment of autoimmune and inflammatory disorders'20158,785,441'3-phenyl-pyrazole derivatives as modulators of the 5-HT2A serotonin receptor useful for the treatment of disorders related thereto'20148,580,841'Substituted 1,2,3,4-tetrahydrocyclopenta[b]indol-3-yl)acetic acid derivatives useful in the treatment of autoimmune and inflammatory disorders'20138,546,429'1,2,3-trisubstituted aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto'20138,415,484'Substituted tricyclic acid derivatives as S1P1 receptor agonists useful in the treatment of autoimmune and inflammatory disorders'20138,362,248'Substituted pyridinyl and pyrimidinyl derivatives as modulators of metabolism and the treatment of disorders related thereto'20138,101,626'GPR119 receptor agonists in methods of increasing bone mass and of treating osteoporosis and other conditions characterized by low bone mass, and combination therapy relating thereto'20127,884,101'3-phenyl-pyrazole derivatives as modulators of the 5-HT2A serotonin receptor useful for the treatment of disorders related thereto'20117,838,525'Trisubstituted aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto'20107,816,364'GRP119 receptor agonists in methods of increasing bone mass and of treating osteoporosis and other conditions characterized by low bone mass, and combination therapy relating thereto'20107,470,699'Trisubstituted aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto'2008Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2008–2020Patents assigned to ARENA PHARM INC (17)· patent assignee history
2008–2020Based in San Diego, CA, US· patent location history
2012–2014Patents assigned to JONES ROBERT M (6)· patent assignee history
2012–2014Patents assigned to LEHMANN JUERG (6)· patent assignee history
2013Patents assigned to BUZARD DANIEL J (2)· patent assignee history
2013–2014Patents assigned to CHOI JIN SUN KAROLINE (2)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| ARENA PHARM INC | 17 | 2008–2020 |
| JONES ROBERT M | 6 | 2012–2014 |
| LEHMANN JUERGself | 6 | 2012–2014 |
| BUZARD DANIEL J | 2 | 2013 |
| CHOI JIN SUN KAROLINE | 2 | 2013–2014 |
Locations
| Location | Patents | Span |
|---|---|---|
| San Diego, California, US | 17 | 2008–2020 |